Kilitch Drugs(I) merger & restructuring announcements

Every Kilitch Drugs(I) merger & restructuring announcement on NSE and BSE, newest first, each with its own page.

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements

23 Oct 2026 15:15 IST BSE

Merger & Restructuring Kilitch Drugs(I) Ltd KILITCH

Kilitch Drugs(I) Merger & Restructuring Worth ₹131.6 Cr

Kilitch Drugs will divest its entire Ethiopian subsidiary stake to HarmeeCare for US$14 million (~₹131.6 Crore). Proceeds will fund debt repayment and Pen plant expansion.

Value: ₹131.6 Cr

Open announcement → Read the filing ↗

22 Oct 2026 20:18 IST BSE

Merger & Restructuring Kilitch Drugs(I) Ltd KILITCH

Kilitch Drugs(I) Merger & Restructuring Worth ₹120.8 Cr

Kilitch Drugs will divest its 100% stake in subsidiary Kilitch Estro Biotech PLC for USD 12.855 million (approx. ₹120.84 Crore).

Value: ₹120.8 Cr
From: HarmeeCare Pharmaceuticals

Open announcement → Read the filing ↗